ACT017 is a Fab fragment of humanized anti-GPVI monoclonal antibody. ACT017 inhibits collagen-induced platelet aggregation. ACT017 has the potential for the research of acute ischemic stroke[1][2].
Molecular Weight:
(48.29 kDa)
Purity:
99.00
CAS Number:
[2101829-58-5]
Formula:
CHT17
Target:
Glycoprotein VI
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
